Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
K.G. Reddy, R.N. Nair, H.M. Sheehan, J.M. Hodgson.
Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis.
J Am Coll Cardiol, 23 (1994), pp. 833-843
[2.]
J.K. Liao, W.S. Shin, W.Y. Lee, S.L. Clark.
Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase.
J Biol Chem, 270 (1995), pp. 319-324
[3.]
J.H. Chin, S. Azhar, B.B. Hoffman.
Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
J Clin Invest, 89 (1992), pp. 10-18
[4.]
R.H. Boger, S.M. Bode-Boger, A. Szuba, P.S. Tsao, J.R. Chan, O. Tangphao, et al.
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
Circulation, 98 (1998), pp. 1842-1847
[5.]
R.A. Mangiafico, L.S. Malatino, M. Santonocito, R.S. Spada, G. Polizzi, G. Tamburino.
Raised plasma endothelin-1 concentrations in patients with primary hypercholesterolemia without evidence of atherosclerosis.
Int Angiol, 15 (1996), pp. 240-244
[6.]
G. Nickenig, A.T. Baumer, Y. Temur, D. Kebben, F. Jockenhovel, M. Bohm.
Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.
Circulation, 100 (1999), pp. 2131-2134
[7.]
R. Hambrecht, A. Wolf, S. Gielen, A. Linke, J. Hofer, S. Erbs, et al.
Effect of exercise on coronary endothelial function in patients with coronary artery disease.
N Engl J Med, 342 (2000), pp. 454-460
[8.]
R.M. Tomaino, E.A. Decker.
High-fat meals and endothelial function.
Nutr Rev, 56 (1998), pp. 182-185
[9.]
A.M. Zehier, V. Schächinger, S.H. Hohnloser, B. Saurbier, H. Just.
Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis.
Circulation, 89 (1994), pp. 2525-2532
[10.]
O. Hernández-Perera, D. Pérez-Sala, J. Navarro-Antolín, R. Sánchez-Pascuala, G. Hernández, C. Díaz, et al.
Effects of 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
J Clin Invest, 101 (1998), pp. 2711-2719
[11.]
W.H. Kaesemeyer, R.B. Caldwell, J. Huang, R.W. Caldwell.
Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions.
J Am Coll Cardiol, 33 (1999), pp. 234-241
[12.]
J.K. Williams, G.K. Sukhova, D.M. Herrington, P. Libby.
Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys.
J Am Coll Cardiol, 31 (1998), pp. 684-691
[13.]
T.J. Anderson, A. Uehata, M.D. Gerhard, I.T. Meredith, S. Knab, D. Delagrange, et al.
Close relation of endothelial function in the human coronary and peripheral circulations.
J Am Coll Cardiol, 26 (1995), pp. 1235-1241
[14.]
R. Pedrinelli, G. Dell’Omo, A. Gimelli, Bello V Di, L. Talarico, A. Corchia, et al.
Myocardial and forearm blood flow reserve in mildmoderate essential hypertensive patients.
J Hypertens, 15 (1997), pp. 667-673
[15.]
J.M. Mostaza, M.V. Gómez, F. Gallardo, M.L. Salazar, R. Martín-Jadraque, L. Plaza-Celemín, et al.
Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels.
J Am Coll Cardiol, 35 (2000), pp. 76-82
Copyright © 2001. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.